Abstract: The invention provides oligomer-bis-chromonyl compound conjugates. The conjugates of the invention, when administered by any of a number of administration routes, exhibits advantages over previously administered compounds.

Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.

Abstract: Disclosed is a method and mobile terminal for drawing sliding track. The method comprises: A) obtaining the total sliding distance and the total sliding time for sliding from the sliding start position to the sliding end position; B) drawing the sliding track of the current frame image in the sliding start position, recording the current time for finishing the drawing of the current frame image; C) obtaining the drawing time from the drawing start time to the current time for finishing the drawing of the current frame image, judging whether the drawing time is greater than or equal to the total sliding time, if no, performing the step D, if yes, performing the step E; D) according to the drawing time, the total sliding time and the total sliding distance, obtaining the current sliding distance, replacing the sliding start position by the sum of the sliding start position and the current sliding distance, returning to the step B; E) drawing the sliding track of the last frame image in the sliding end position.

Abstract: The invention relates to (among other things) methods for treatment comprising administering oligomer-containing substituted aromatic triazine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.

Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.

Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.

Abstract: A login method and device, and a terminal and a network server are disclosed, which relate to communications technologies. In the method, acquire an account waiting for login and a first password, and judge whether the first password is the same as a local password bound with the pre-stored account. If the first password is the same as the local password bound with the pre-stored account, upload a second password corresponding to the pre-stored account to a network server for matching, and log in to the account once the second password is successfully matched. The present invention introduces a custom password (i.e., the first password), thus avoids the complexity to enter an actual login password (i.e., the second password) and the unsafety to remember the actual login password in a terminal, and enhances the convenience and safety for login and offers greater user experience.

Abstract: The invention relates to (among other things) methods for treatment comprising administering oligomer-containing substituted aromatic triazine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.

Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water soluble oligomer.

Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer.

Abstract: The invention relates to (among other things) methods for treatment comprising administering oligomer-containing substituted aromatic triazine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.

Abstract: A method and an apparatus provide network problem location based on subscriber perception. A server firstly receives and parses a call history record CHR log sent by a network management system, then determines, according to a parsing result, whether a call of a subscriber is a key quality indicator KQI exception event, and locates a location and a cause of the KQI exception event. The technical solutions provided in the present invention are capable of finding a network problem and locating the network problem from the perspective of subscriber perception.

Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.

Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer.

Abstract: The invention relates to (among other things) oligomer-containing substituted aromatic triazine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.

Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.

Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water soluble oligomer.

Abstract: The present disclosure is applicable to the technical field of image processing and provides a method and device for wallpaper cropping operations. The method separates and carries out the vertical and horizontal wallpaper cropping operations independently.

Abstract: A method includes outputting a first signal from a first DAC decoder circuit in response to receiving a first number of bits of a digital control signal, outputting a second signal from a second DAC decoder circuit in response to receiving a second number of bits of the digital control signal, and alternately outputting one of the first and second signals to an LCD column from a buffer coupled to the first and second DAC decoder circuits. The first signal has a voltage level equal to one of a first plurality of voltage levels received at one of a first plurality of inputs of the first DAC decoder circuit. The second signal has a voltage level equal to one of a second plurality of voltage levels received at one of a second plurality of inputs of the second DAC decoder circuit.

Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water-soluble oligomer.